Constellation Pharmaceuticals Announces Second-Quarter 2020 Financial Results, Provides Regulatory Update

    NEXT STORY
    Worldwide Post-Pandemic Healthcare Market Study 2020 – COVID-19 Impact
    PREV STORY
    Affimed Announces Two New Appointments to Its Supervisory Board
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    PetLife Pharmaceuticals’ CEO Dr. Salvagno Provides White Paper on “Venenotherapy” While Preparing for FDA Submission

    Hancock, MD, Dec. 06, 2016 (GLOBE NEWSWIRE) -- PetLife Pharmaceuticals, Inc. (OTC QB: PTLF) ...

    author_avatar
    NASDAQ Market News

    Intellia Therapeutics Names Fred Cohen, M.D., to Board of Directors

    author_avatar
    NASDAQ Market News

    Onxeo Provides Strategy Update and Reports 2017 Third Quarter Financial Information

    Company completes strategic shift to innovative DNA-targeting programs and platON™ chemistry platform of decoy ...

    author_avatar
    NASDAQ Market News